# Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients

> **NCT05314673** · PHASE4 · COMPLETED · sponsor: **University Hospital Fattouma Bourguiba** · enrollment: 60 (actual)

## Conditions studied

- Pterygium

## Interventions

- **DRUG:** Preoperative Intra-lesional Bevacizumab Injection in primary pterygium
- **PROCEDURE:** pterygium surgery without adjunctive therapy

## Key facts

- **NCT ID:** NCT05314673
- **Lead sponsor:** University Hospital Fattouma Bourguiba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05314673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05314673, "Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05314673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
